Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
重组合异种骨修复良性骨肿瘤术后骨缺损的疗效观察
Hits: 1906   Download times: 1380   Received:September 20, 2005    
作者Author单位UnitE-Mail
焦锋 JIAO Feng 广州市花都区中医院骨伤科,广东广州510800 The Huadu TCM Hospital of Guangzhou,Guangzhou 510800,Guangdong,China queenjj1987@yahoo.com.cn 
期刊信息:《中国骨伤》2005年18卷,第12期,第733-734页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz


目的:观察一种复合异种骨修复良性骨肿瘤手术切除后骨缺损的临床疗效。

方法:重组合异种骨(RBX)治疗36例良性骨肿瘤手术后的骨缺损,其中男20例,女16例;年龄8~62岁,平均31岁。观察手术后的并发症及骨愈合情况。

结果:获得随访32例,平均随访时间12个月,最短10个月,最长24个月。有一例并发术后感染,26例在第9个月经X线片和CT证实获得骨性愈合,在随访期内未发生肿瘤复发。

结论:RBX是一种较为理想的骨缺损修复材料,对良性骨肿瘤术后骨缺损的修复具有较为可靠的疗效。
[关键词]:骨瘤  骨移植  移植,异种  手术后并发症
 
Therapeutic effects of recombination grafting of heterologous bone for repairing of postoperative bone defects of benign bone tumor
Abstract:

Objective: To study therapeutic effects of recombination heterologous bone grafting for repairing of postoperative bone defects of benign bone tumor.

Methods:Thirty-six patients with postoperative bone defects of benign bone tumor were treated with recombination heterologous bone grafting.Among all 36 patients,20 were male,16 were female,with ages from 8 to 62 years,averagely 31 years.Postoperative complications and bone healing were observed.

Results:Thirty-two patients were followed up from 10 to 24 months,with an average of 12 months.Postoperative infection occurred in 1 patient,and 26 patients obtained bone healing which were confirmed by X-ray and CT examination at 9th month after treatment.There were no tumor recurrence during follow-up period.



Conclusion:
Recombination of heterologous bone is an ideal method to repair bone defect,based on the present results that it was effective in repairing operative bone defect of benign bone tumor.
KEYWORDS:Osteoma  Bone transplantation  Transplantation,heterologous  Postoperative complications
 
引用本文,请按以下格式著录参考文献:
中文格式:焦锋.重组合异种骨修复良性骨肿瘤术后骨缺损的疗效观察[J].中国骨伤,2005,18(12):733~734
英文格式:JIAO Feng.Therapeutic effects of recombination grafting of heterologous bone for repairing of postoperative bone defects of benign bone tumor[J].zhongguo gu shang / China J Orthop Trauma ,2005,18(12):733~734
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com